Japan Bioventures SymBio, GNI Spread U.S. Wings
This article was originally published in PharmAsia News
Executive Summary
Trying to address some of the expansion challenges faced by their peers, two Japanese bioventures have taken steps to boost their presence and profile in the U.S.